News

Spineart today announced that its ROMEO®2 25D deformity screw was used for the first time in a spinal deformity surgery. The surgery was performed successfully at the University of California, Irvine Medical Center by Dr. Nitin Bhatia, Chief of Spinal Surgery, and Dr. S. Samuel Bederman, Fellowship-trained orthopaedic spine surgeon specializing in complex deformity reconstruction and degenerative disorders. “The use of the ROMEO®2 25D deformity screw allowed us to correct the patients scoliosis more safely and effectively than may have otherwise been possible,” said Dr. Bhatia.
The development of the ROMEO®2 25D deformity pedicle screw marks a technological leap forward in treating complex spinal deformities. The new innovative screw conveniently combines the advantages of a monaxial and polyaxial screw and assists in coronal corrections by segmentally pulling the spine to match a contoured rod and in axial correction by de-rotating the vertebral body during rod reduction. When using the ROMEO®2 25D deformity screw, forces are spread over multiple levels which help reduce the risk of screw pullout during reduction maneuvers.

For more information please contact us at contact@spineart.com

About Spineart:
Spineart delivers pioneering, safe and efficient solutions to spine surgeons, operating room teams and patients.
Spineart, present in 47 countries, offers a full range of high quality Swiss Made Fusion, Motion, and MIS devices worldwide, focusing on simplicity and safety of use.
Spineart markets a complete portfolio of traceable barcoded sterile packed implants and is thereby proudly promoting higher safety, cost-efficiency, and compliance at the hospital.

Geneva, July 1st, 2013.
Spineart accelerates its international development through its newly established German subsidiary.
Spineart announced today the opening of its German subsidiary, Spineart GmbH, effective July 1st 2013.
After 3 years of a successful and fruitful collaboration, Spineart and Sanofi-Aventis mutually agreed to terminate their exclusive distribution agreement in Germany. As part of the agreement Spineart Deutschland GmbH will progressively take over Sanofi Spine German distribution activities and sell directly in Germany, the largest European spine market. A transition period until the end of the year will allow a smooth and professional business transition.
In line with its strategy to address major markets, Spineart is now selling directly in the US, France, Switzerland, Italy, Austria and Germany with more announcements to be made before the end of the year.

About Spineart:

Spineart delivers pioneering, safe and efficient solutions to spine surgeons, operating room teams and patients.
Spineart, present in 47 countries, offers a full range of high quality Swiss Made Fusion, Motion, and MIS devices worldwide, focusing on simplicity and safety of use.

Spineart markets a complete portfolio of traceable barcoded sterile packed implants and is thereby proudly promoting higher safety, cost-efficiency, and compliance at the hospital.1

We are pround to announce that after 3 years of a fruitful collaboration, Sanofi-Aventis Deutschland GmbH and Spineart SA have mutually agreed to terminate the distribution agreement of the Spineart product portfolio in Germany. After a progressive transition period from July 1 to December 31, 2013, direct commercialization and distribution of the Spineart brands in Germany will be performed exclusively by Spineart Deutschland GmbH the German affiliate of Spineart SA.

For any further information, please contact:

Mr Jérôme VENTURA
President of Spineart SA
jventura@spineart.com

Mr Jérôme TRIVIDIC
Executive Vice President
jtrividic@spineart.com27

SPINEART and GE Healthcare hosted a lab at the University of Hamburg. This lab gave 40 participants from 12 countries the opportunity to learn more about the latest in motion preservation methods and to train on M.I.S. surgical techniques with emphasis on the screwless and K-wireless technologies. Included in this training were interactive presentations and hands-on anatomical workshops hosted by an internationally renowned surgeon faculty from Germany, Belgium, the US and France. Additionally we hosted separate theoretical and bioskills sessions in Russian, which was an exciting first for us.

Geneva, 21 February 2013. Spineart is pleased to announce that, as of the 31st of December 2012, more than 8’200 BAGUERA®C had been implanted successfully worldwide. The first surgery was held in France in January 2007. Since then, this device has been implanted in 25 countries.

BAGUERA®C, a cervical disc prosthesis of lastest generation, is the first pre-assembled and MRI compatible disc with a guided mobile PE nucleus and designed to absorb shocks.

All Spineart implants are sterile packed and bar-coded for increased safety, procedure compliance and cost-efficiency.

This product is not yet available in the US. For more information, please contact us at contact@spineart.com

Spineart, the international pure spine company offering a full range of Swiss made Fusion, Motion and M.I.S. spinal implants focused on simplicity and safety of use, announced the opening of a direct sales and distribution subsidiary in Italy, Spineart Italia Srl. Spineart is strengthening its relationships with Italian surgeons and hospitals by establishing a network of direct salesforce and local distributors solely focused on this market. Spineart’s expansion into Italy will be supported by the rapid adoption in this country of its recently launched ROMEO®2 PAD I.S.P.F. device and ROMEO®2 M.I.S. K-wireless system. The first ROMEO®2 M.I.S. K-wireless surgery and first ROMEO®2 PAD I.S.P.F. surgery under the new organization were performed in January 2013. “Spineart’s international expansion continues to gain momentum and the direct distribution of our products in Italy follows our strategy of strengthening our leadership position within the European medical device companies” stated Jérôme Trividic, Spineart SA’s Executive Vice President.

For more information, please contact us at contact@spineart.com